NCT03086681 2025-07-29
ECWHCCFLACC
First Affiliated Hospital of Guangxi Medical University
Phase 2 Completed
Clinical Trials
4 trialsNCT03797625 2025-07-23
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Fudan University
Phase 2 Completed
NCT06617936 2025-07-15
Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.
Shandong Public Health Clinical Center
Phase 2 Recruiting
NCT06965231 2025-05-11
FUMS-EDJS2024
Fudan University
Phase 2 Recruiting